新京报讯（记者陈琳）北京市东城区第十七届人民代表大会第六次会议正在举行。1月14日，东城区卫 生健康委主任曾文军介绍，2025年东城区人均预期寿命达84.59岁，位居全国前列。 强化基层服务能力，开展家庭病床服务试点，开展居家医养联合体试点建设，推动社区卫生与养老服务 资源整合衔接。深化疾控体系改革，推进智慧疾控建设，完善智能监测预警体系，建设区级慢病防治管 理中心。 2025年，东城区医疗资源布局持续优化，医联体建设取得新突破，区第一人民医院新址开诊后门急诊人 次同比增长7%，9家区级医院实现检查检验结果线上共享互认。 基层医疗服务网络进一步夯实，社区医疗机构上转和接收下转人次数同比增长超20%。推动第六医院医 疗集团、和平里医院医疗集团建设，构建网格化医疗服务新格局。在中医药发展方面，东城区获评国家 中医药传承创新发展示范项目试点，打造前门广誉远（600771）"博物馆+国药堂+国医馆"一体化发展 模式，推动"中医药+"融合发展。 在重点人群健康服务上，家庭医生签约服务与居家养老实现深度融合，连续9年获全市基层卫生绩效考 核优秀。针对老年人群，搭建区级老年痴呆全病程服务协作网；保障母婴健康，辖区早孕门诊建 ...

Core Insights - Beijing's health commission has released two key documents outlining plans for the development of AI applications in the healthcare sector from 2026 to 2027, aiming to establish a supportive AI industry framework by 2027 [1][2] - The core principle of the policies is "demand-driven, scenario-based," focusing on enhancing clinical diagnosis, grassroots health, and health management, while encouraging collaboration between medical institutions and quality AI companies [1][2] Group 1: Policy Objectives - The goal is to create an AI industry support system that facilitates precise demand matching, efficient data flow, rapid technology transfer, and collaborative ecosystem development [1] - The policies prioritize high-frequency and high-value medical scenarios, aiming to improve diagnostic efficiency and optimize healthcare resource supply [1][2] Group 2: Data Utilization and Security - The implementation of these policies relies on effective data utilization, with plans to integrate electronic medical records and imaging data from secondary and tertiary medical institutions into a comprehensive health information platform by the end of 2026 [2] - A governance system for the entire data lifecycle will be established to ensure data security and privacy, while also supporting AI model training and validation [2] Group 3: Industry Collaboration and Ethical Standards - The AI ecosystem in healthcare requires collaboration between medical enterprises, integrating computing power, models, data, applications, and scenarios to build a diversified industry ecosystem [2] - The policies emphasize ethical standards and patient safety, prohibiting the complete replacement of medical professionals' judgment by AI [2] Group 4: Support and Infrastructure - The health commission plans to seek multi-channel funding support and focus on infrastructure development, application promotion, and talent cultivation to ensure the successful implementation of the policies [2] - Specific initiatives include the establishment of dedicated computing clusters for healthcare and creating online platforms for precise supply-demand matching [2] Group 5: Practical Applications and Industry Response - Several medical institutions in Beijing have already begun to benefit from AI technologies, with successful implementations in areas such as AI-assisted diagnosis and imaging [3] - Companies are optimistic about leveraging high-quality health data from the health commission to enhance the precision and efficiency of stem cell research and development [3] - The introduction of these policies is a strategic move to leverage Beijing's advantages in the AI industry chain and rich medical resources, aligning with the national "Artificial Intelligence +" strategy [3]

Core Viewpoint - The A-share market started 2026 on a positive note, with all three major indices rising, indicating a shift from valuation recovery in 2025 to profit-driven growth in 2026 [1][5][12] Market Performance - On January 5, 2026, the Shanghai Composite Index rose by 1.38% to 4023.42 points, the Shenzhen Component increased by 2.24% to 13828.63 points, and the ChiNext Index saw a rise of nearly 2.9% to 3294.55 points [5] - The total trading volume reached 2.57 trillion yuan, an increase of over 500 billion yuan compared to the previous trading day, with nearly 4200 stocks rising [6] Key Drivers - The "opening red" of the A-share market was attributed to multiple positive factors, including improved market sentiment, expectations of long-term capital inflows, and strong anticipation of further macroeconomic growth policies [6][12] - The technology sector, particularly AI, semiconductor, and brain-computer interface stocks, showed strong performance, contributing significantly to the index's rise [7][8] Sector Highlights - The brain-computer interface sector experienced a surge, with stocks like Beiyikang and Sanbo Brain Science hitting the daily limit, driven by news of overseas company Neuralink's plans for large-scale production [10][11] - Other sectors such as AI applications, medical devices, and insurance also performed well, with respective index increases of 9.95%, 6.83%, and 6.72% [8] Investment Opportunities - Institutions are focusing on technology growth, advanced manufacturing, and cyclical consumption for investment opportunities in 2026 [2][14] - A balanced investment strategy is recommended, emphasizing high-quality stocks alongside high-potential sectors such as non-bank financials, humanoid robots, and AI hardware [14][15] - The pharmaceutical sector is expected to present structural opportunities, particularly in innovative drugs and AI integration in healthcare [15]

Group 1: Market Overview - The global M&A market shows signs of recovery in 2025, with China's M&A market experiencing a fundamental reshaping of rules, leading to a near doubling of the number of M&A approvals and a significant increase in major restructuring transaction volume compared to the past six years [1] - In 2025, the number of disclosed M&A events by A-share companies reached 4,044, with 147 major asset restructuring projects, a year-on-year increase of 44.12%, and the number of major asset restructuring approvals was 29, nearly doubling from 2024 [3] - The global M&A market in 2025 saw a transaction value of approximately $4.5 trillion, a nearly 50% year-on-year increase, marking the second-highest in history [7] Group 2: Policy Environment - The "14th Five-Year Plan" emphasizes a positive positioning for M&A and restructuring, aiming to support listed companies in transformation and upgrading, enhancing market efficiency through a set of policy measures [2] - The new "National Nine Articles" and "M&A Six Articles" are expected to create a policy environment that encourages industrial mergers and enhances market efficiency [2] Group 3: Sector Trends - The technology sector is becoming a focal point for M&A, with significant activity in areas such as AI, quantum computing, and advanced materials, driven by the need for companies to enhance operational efficiency and innovate [6] - The healthcare sector is also seeing increased M&A activity, particularly in biotech companies with breakthrough therapies, as well as in digital health and telemedicine, driven by rising demand for innovative treatments [9] Group 4: Future Outlook - In 2026, the M&A market is expected to benefit from continued policy optimization, with a focus on technology empowerment and industrial integration, particularly in traditional industries undergoing digital transformation [5][6] - The capital market is anticipated to support M&A activities through improved refinancing mechanisms, with a focus on high-quality assets and sectors such as new energy, innovative pharmaceuticals, and infrastructure [10][11]

Core Viewpoint - China is undergoing a "scene revolution" aimed at driving growth, reform, and governance optimization through the large-scale application of new technologies and products, as outlined in the recently approved "Implementation Opinions" by the State Council [2][3][4]. Group 1: Background and Current State - China has a solid foundation for advancing the scene revolution, with adequate scene resources, institutional environment, infrastructure, and construction experience [3][6]. - The country faces challenges such as an inadequate revenue mechanism, fragmented resources, administrative and market barriers, and a lack of transformation service systems that hinder scene cultivation and openness [3][9]. Group 2: Strategic Importance - The "14th Five-Year Plan" emphasized innovation as central to modernization, but many technological achievements remain in the pilot stage, necessitating the application of these technologies in real, scalable scenes [4][5]. - The scene revolution is crucial for transforming new demands into economic vitality and restoring market confidence by facilitating the supply-demand cycle [5][10]. Group 3: Policy Framework - The "Implementation Opinions" marks a significant national-level policy initiative to systematically deploy tasks related to scene cultivation and openness, identifying five major market areas and 22 key scenes [10][11]. - The focus is on creating new application scenes in emerging fields, upgrading traditional industries, and addressing urgent needs in various sectors such as emergency management and social governance [11][12][13][14]. Group 4: Infrastructure and Technological Support - China has made significant advancements in new infrastructure, including 5G networks and data centers, which support the widespread application of technologies like big data and artificial intelligence [7]. - The establishment of over 470,500 5G base stations and extensive fiber optic networks has positioned China as a leader in global network infrastructure [7]. Group 5: Industry and Market Opportunities - The scene revolution is expected to unlock a trillion-level market by fostering new business models and enhancing the integration of technology across various sectors [10][15]. - The healthcare sector is projected to see substantial growth, with the smart healthcare market expected to exceed 270 billion yuan by 2030, driven by digital transformation [15]. Group 6: Collaborative Ecosystem - A collaborative ecosystem involving central and local governments, state-owned enterprises, and private companies is essential for nurturing scene-driven innovation [16][19]. - The emphasis is on creating a supportive environment for all stakeholders to participate in scene cultivation and innovation, ensuring equitable access to resources and opportunities [17][18].

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 投资者提问：尊敬的董秘您好！据悉公司被列入"中国数谷"数据要素"改革沙盒"第二批试点企业，可在 监管沙盒内合规开展数据要素流通与增值应用。公司手握近500家医院的合规脱敏大数据，并在"慧康- 启真"大模型上已把AI辅助诊断的准确率提升42%。请问：1.这些高质量数据是否已向互联网医疗平台 开放接口？2.后续有无计划与蚂蚁"阿福"等具备亿级C端流量的互联网生态合作，联合推出AI导诊/慢病 管理产品，以快速 创业慧康回复：尊敬的投资者，您好！感谢您的关注。公司作为"中国数谷"数据要素改革试点企业，始 终将数据合规与安全置于首位，业务开展严格遵循"数据可用不可见"及"原始数据不出域"原则，通过大 模型及数据可信空间提供AI辅助与增值服务，不涉及向第三方直接开放原始数据接口。在生态合作方 面，公司秉持开放共赢理念，对与包括具备流量优势的互联网平台在内的各类伙伴合作持积极态度，致 力于共同赋能医疗机构以更好地服务C端患者；如有达到披露标准的重大合作进展，公司将严格履行信 披义务，请以指定媒体公告 ...

Group 1 - The core viewpoint of the news is that Jinan has made significant advancements in integrating artificial intelligence (AI) into healthcare services, improving efficiency and patient experience [1][4] - Jinan has established a unified computing power platform that supports 13 medical institutions, with over 3 billion calls made, reducing costs and burdens for individual medical facilities [1] - AI-assisted diagnosis has provided over 40 million diagnostic aids, with an electronic medical record standardization rate of 89.9%, enhancing the capabilities of primary healthcare institutions [1] Group 2 - Jinan has built a regional imaging cloud platform that allows for cross-hospital access to examination results, saving patients from carrying physical films, and has achieved over 700,000 mutual recognitions of test results, saving patients over 50 million RMB [2] - The city has implemented a foodborne disease monitoring information system covering over 160 grassroots health institutions, providing key support for early warning and efficient handling of public health emergencies [4] - Jinan has launched a digital application for adult vaccine prescriptions in 29 community health service centers, extending healthcare services from hospital treatment to community health management [4] Group 3 - Jinan has made significant progress in health services for key populations, being selected as a national demonstration city for infant care services, with a ratio of 5 care spots per 1,000 people [6] - The city has achieved a 98% creation rate for elderly-friendly medical institutions and full coverage of geriatric medicine departments in secondary and higher-level hospitals [6] - By the end of 2024, Jinan is expected to have 8,462 medical and health institutions, 88,800 beds, and 130,900 health technicians, with core health indicators continuously improving [6]

Investment Rating - The report rates the AI precision medicine industry as having a positive investment outlook, with significant growth potential driven by technological advancements and policy support [10][39]. Core Insights - AI precision medicine is transforming healthcare from experience-based to data-driven approaches, emphasizing personalized treatment through genetic testing and big data [9][10]. - The market for AI precision medicine is expected to grow rapidly, with projections indicating a market size of 351 billion RMB by 2024 and 760 billion RMB by 2028, reflecting a compound annual growth rate (CAGR) of 21.49% [39]. - The integration of AI technologies into healthcare is enhancing diagnostic accuracy, treatment efficiency, and patient experience, addressing the challenges of uneven resource distribution in the healthcare system [17][40]. Summary by Sections Evolution of AI Precision Medicine - The evolution of AI precision medicine has progressed from research achievements to clinical applications, with significant advancements in technology and policy frameworks supporting this transition [8][9]. Policy Support - Policies are driving the development of a comprehensive and accessible precision medicine framework, enhancing regulatory systems and approval processes to facilitate the integration of AI in healthcare [10][11]. Market Trends - The AI precision medicine market is expanding rapidly, with a projected CAGR of 19.8% from 2022 to 2024 and 21.49% from 2024 to 2028, indicating strong growth potential [37][39]. Technological Advancements - AI technologies are significantly improving diagnostic capabilities, with advancements in multi-modal data integration and real-time health monitoring enhancing patient care and treatment outcomes [26][71]. Application Scenarios - AI is being applied in various healthcare settings, including personalized treatment plans, early disease detection, and long-term health management, thereby transforming traditional healthcare models [43][40]. Industry Collaboration - The report highlights the importance of collaboration across the healthcare ecosystem, leveraging data and AI to create a more integrated and efficient healthcare delivery system [78][79].

Core Insights - The consensus in the medical industry is that AI will not replace doctors but will serve as an essential assistant, supported by a strong regulatory framework [2] - The AI medical sector is transitioning from conceptual hype to substantial development driven by policies and market forces, with a projected industry scale of 115.7 billion yuan by 2025 [3][4] - The integration of AI into various medical applications is deepening, with significant advancements in areas such as imaging analysis and drug development [4][10] Industry Growth and Projections - The AI medical industry in China is expected to reach 115.7 billion yuan by 2025, with a compound annual growth rate of 10.5% from 2022 to 2028 [3] - By 2028, the industry scale is projected to increase to 159.8 billion yuan [3] Application Maturity and Areas of Focus - AI applications have expanded from diagnostic tools to encompass drug development, decision support, and medical robotics, with imaging analysis being the most mature area [4][10] - AI in medical imaging is projected to exceed 15 billion yuan by 2025, with a significant increase to 23.57 billion yuan by 2026 [10] Data Infrastructure and Challenges - As of July 2025, 206 algorithmic medical products have been registered, with 160 companies providing AI services directly to patients through apps [6] - The quality and standardization of medical data remain significant challenges, with a large volume of data being poorly structured and difficult to utilize effectively [21][22] Payment and Commercialization Issues - The integration of AI into the payment system is still developing, with current regulations preventing additional charges for AI-assisted diagnoses [23] - The recognition of AI's clinical value is crucial for its inclusion in payment systems, with a focus on demonstrating its effectiveness in improving patient outcomes [23][24] Future Directions and Sustainable Development - The AI medical sector is exploring diverse commercialization paths, with a focus on creating clear clinical value to ensure sustainability [27][30] - The concept of "inclusive healthcare" is emerging as a key focus, aiming to balance service quality, accessibility, and cost [30]

Core Insights - The volume of remote medical imaging diagnostic services in county areas has exceeded 68 million this year, supported by the integration of "artificial intelligence+" in healthcare [1] - Over 90% of residents can access nearby medical services within 15 minutes, with the proportion of outpatient visits at grassroots medical institutions expected to reach 63.4% of the national total in 2024, an increase of 0.5 percentage points from the previous year [1] - The establishment of 12 pilot comprehensive health service zones since 2021 has led to a diagnostic volume share of 69.1% in these areas by 2024, surpassing the national average [1] Group 1 - In Guangxi, the construction of a national comprehensive pilot zone in Upshi County is being supported, along with the establishment of one autonomous regional grassroots health comprehensive pilot zone in each of the 14 districts and cities [2] - The Guangxi Health Commission is implementing AI-assisted diagnosis and chronic disease management, with a goal of deploying the system in over 50% of grassroots institutions by 2026 [2] - The integration of AI in healthcare is expected to enhance the identification accuracy of common and frequently occurring diseases, particularly in early screening for local diseases such as nasopharyngeal carcinoma and thalassemia [2] Group 2 - The construction of key specialty departments, such as oncology, psychiatry, and ophthalmology, has significantly improved service capacity and availability in county-level hospitals due to the empowerment of artificial intelligence [2]